1Progress in viral targets for anti-HBV agentsYAO Wei-ming, XU Dong-ping323-3262Alert on transfusion-transmitted chronic hepatitis EZHANG Li, WANG You-chun327-330,3423Research and prospect of biotherapy and cell therapy in severe liver diseasesZANG Hong, YOU Shao-li, XIN Shao-jie331-3334Down-regulation effect of HBV genome pre-S deletion mutation on viral replication capacity and the transcriptional activity of the overlapping surface antigen promoterⅡMIAO Fu-zhen, XU Zhi-hui, LIU Yan, LI Qi, LI Xiao-dong, YAO Wei-ming, XIN Shao-jie, LI Jin, XU Dong-ping334-3385rtA181S mutation in the reverse-transcriptase domain of HBV is associated with adefovir dipivoxil resistanceYANG Jing, LIU Yan, CHEN Rong-juan, XU Zhi-hui, CHEN Li, XIN Shao-jie, LIU Xin-guang, XU Dong-ping339-3426Expression of myeloid-derived suppressor cells in peripheral blood in patients with HBV-related acute-on-chronic liver failureLI Chen, LIU Hong-ling, ZANG Hong, ZHU Bing, CHEN Jing, LIU Wan-shu, YOU Shao-li, XIN Shao-jie343-347,3577Association between serum levels and single nucleotide polymorphisms of CXCL10 and thyroid dysfunction in patients with chronic hepatitis CSHAO Cui-ping, HUO Na, FAN Xiao-hong, ZHENG Ying-ying, BAO Yi, LI Fang, LI Min-ran, LU Hai-ying, XU Xiao-yuan348-350,3548Inhibition of the activation of nuclear factor kappa-light-chain-enhancer of activated B cells by M fragments of new type of reovirusBAI Bing-ke, TAO Ling, SHEN Hong-hui, HOU Jun, HU Yan, LUO Sheng-dong, YANG Rui-chuang, MAO Pan-yong351-3549Clinical significance of quantitative detection of Brucella DNA in serum samplesZHENG Wen-yan, ZHANG Ju-ling, ZHANG Zhuan-cai, YAN Fei, QU Fen355-35710Retrospective analysis of the effect of nucleoside analogues on HBV reactivation due to glucocorticoid therapyXIA Xu-hui, CHEN Xin358-36111Epidemiological features of Chinese Burmese patients with chronic hepatitis C in the People's Hospital of Dehong Prefecture, Yunnan Province, ChinaWANG Guo-jian, YOU Jing, BAI Jie, DUAN Xing-jun, PAI Yun-zhen, YANG Hong, GAO Zhuo361-36412Progress in genetically-modified animal models of viral hepatitisFAN Chang-fa, MAO Pan-yong, WANG You-chun365-36913Current status of research on hepatitis B and its prevention and treatment in ChinaDING Shan-long, WANG Jie, LU Feng-min369-37214Research progress in HBV/HCV related microRNAsLIU Ning-ning, JIAO Tong, YE Xin373-37715New role of quantitative detection of HBV serum markers in clinical applicationLI Lian-lian, ZHANG Ling, WU Shang-wei378-38216Advances in ultrasound in the diagnosis of bleeding from ruptured hepatocellular carcinomaZHOU Yi-ming, LI Zhi-yan382-38417Analysis of the medical disputes occurring in a third-grade class-A infectious diseases hospitalWANG Fei, LIU Yu-qi, FENG Yu, LI Jin385-386 